- Home
- TSAT vs HQL Comparison
TSAT vs HQL Comparison
Compare TSAT & HQL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TSAT | HQL |
|---|---|---|
| Founded | 1969 | 1992 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Investment Managers |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 697.5M | 585.4M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | TSAT | HQL |
|---|---|---|
| Price | $37.42 | $19.23 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $37.00 | N/A |
| AVG Volume (30 Days) | ★ 202.6K | 137.7K |
| Earning Date | 05-05-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 11.56% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.79 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $24.85 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $19.59 | $13.01 |
| 52 Week High | $59.12 | $21.32 |
Technical Indicators
Market Signals| Indicator | TSAT | HQL |
|---|---|---|
| Relative Strength Index (RSI) | 40.32 | 48.09 |
| Support Level | $28.22 | $16.17 |
| Resistance Level | $43.82 | $21.32 |
| Average True Range (ATR) | 2.61 | 0.53 |
| MACD | -0.02 | -0.17 |
| Stochastic Oscillator | 16.65 | 10.26 |
Price Performance
Historical ComparisonAbout TSAT Telesat Corporation
Telesat Corp is a satellite operator, that provides its customers with mission-critical communications services. It operates in a single operating segment, in which it provides satellite-based services to its broadcast, enterprise, and consulting customers around the world. The company has two operating segments: GEO services (GEO) segment that refers to the operation of the fleet of GEO satellite and LEO services (LEO) segment that refers to the deployment and operation of the Telesat Lightspeed constellation Geographically, it derives a majority of its revenue from Canada. It derives revenue from Broadcast, Enterprise, Consulting, and others.
About HQL abrdn Life Sciences Investors Shares of Beneficial Interest
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mainly in securities of life sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser to have the potential for above-average growth.